FreeView Quiz #2

Q.1

According to the 2014 ACC AHA HRS Guideline for the Management of Patients With Atrial Fibrillation (Exec Sum) p 18 “______________ should not be used to control the ventricular rate in patients with permanent AF as it increases the risk of the combined endpoint of stroke, MI, systemic embolism, or cardiovascular death”

a) Amiodarone
b) Calcium channel antagonists,
c) Digoxin
d) Dronedarone

Q.2

According to the 2010 ACCF/AHA Guidelines on Thoracic Aortic Disease (SUM PDF), p 1559 “Initial management of thoracic aortic dissection”: “If systolic blood pressures remain greater than 120 mm Hg after adequate heart rate control has been obtained, then __________ and/or other vasodilators should be administered intravenously . . . ”

a) nitroprusside
b) angiotensin-converting enzyme inhibitors
c) hydralazine
d) nitroglycerin

Q.3

According to 2011 ACCF/AHA Management of Patients With Peripheral Artery Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic) Pocket Guide p 54, Fig 11 “Management of Abdominal Aortic Aneurysms” For asymptomatic infrarenal AAA “4 cm to 5.4 cm” “Ultrasound scan every 6 to 12 mo” is recommended. For asymptomatic “Pararenal, suprarenal, or Type IV thoraco-abdominal” AAA “4 cm to 5.4 cm”: “ ___________ ” is recommended.

a) Ultrasound scan every 3 mo
b) Ultrasound scan every 6 to 12 mo
c) Contrast CT or MR scan every 3 mo
d) Contrast CT or MR scan every 6 to 12 mo

Q.4

According to the 2013 ACCF/HRS/AHA Appropriate Use Criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy (p 1355, Fig 11) ICD use is “Appropriate” for primary prevention in nonischemic cardiomyopathy with at least 3 months on “guideline-directed medical therapy” under what conditions?

a) “LVEF < / = 35% (NYHA class I-III)”
b) “LVEF < / = 35% (NYHA class III-IV”)
c) “LVEF < / = 40% (NYHA class II-IV)”
d) “LVEF < / = 40% (NYHA class IV)”

Q.5

Please enter your email adress here:

Email